ValGenesis Inc., a global leader in enterprise digital validation lifecycle management, will attend the 33rd Annual ISPE San Francisco Vendor Night on March 19, 2026, at Oracle Park. The event is one of the Bay Area’s largest gatherings for biotechnology, pharmaceutical, and medical device manufacturing professionals, attracting nearly 2,000 attendees.
Executives from ValGenesis will connect with engineers, consultants, academic partners, and government agencies to discuss emerging trends, regulatory challenges, and technology solutions in life sciences manufacturing.
“Vendor Night is more than a networking event,” said David Medina, Chief Marketing Officer at ValGenesis. “It creates space for open dialogue about the challenges facing regulated manufacturing and the technologies that are helping life sciences organizations adapt and grow.”
AI-Driven Digital Validation
ValGenesis is known for Smart GxP™, the industry’s first AI-enabled digital platform for process design, commissioning, qualification, validation (CQV), and ongoing verification across the life sciences. The platform enables organizations to execute GxP workflows with built-in compliance, real-time insights, and risk reduction, accelerating the delivery of high-quality products to market.
Attendees are invited to visit Table No. 55 to meet the ValGenesis leadership team and learn how AI-powered digital validation is reshaping lifecycle management for regulated organizations.
As life sciences manufacturing becomes more complex, AI-enabled platforms like Smart GxP are increasingly critical for ensuring compliance, reducing operational risk, and streamlining product delivery in regulated industries.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
